{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:51:31Z","timestamp":1762865491473},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.bbrc.2009.01.141","type":"journal-article","created":{"date-parts":[[2009,1,30]],"date-time":"2009-01-30T09:24:19Z","timestamp":1233307459000},"page":"775-779","source":"Crossref","is-referenced-by-count":11,"title":["Mechanism of MK-0457 efficacy against BCR\u2013ABL positive leukemia cells"],"prefix":"10.1016","volume":"380","author":[{"given":"Seiichi","family":"Okabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuzo","family":"Tauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko H","family":"Ohyashiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Ohyashiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2009.01.141_bib1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI109193","article-title":"Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells","volume":"62","author":"Fialkow","year":"1978","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2009.01.141_bib2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","article-title":"Fused transcript of ABL and BCR genes in chronic myelogenous leukaemia","volume":"315","author":"Shtivelman","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2009.01.141_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","article-title":"The chronic myelogenous leukemia-specific p210 protein is the product of the BCR\/ABL hybrid gene","volume":"233","author":"Ben-Neriah","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2009.01.141_bib4","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2009.01.141_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/344251a0","article-title":"Acute leukaemia in bcr\/abl transgenic mice","volume":"344","author":"Heisterkamp","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2009.01.141_bib6","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1073\/pnas.87.17.6649","article-title":"Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR\/ABL","volume":"87","author":"Kelliher","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2009.01.141_bib7","first-page":"1269","article-title":"The tetramerization domain-independent Ras activation by BCR\u2013ABL oncoprotein in hematopoietic cells","volume":"12","author":"Tauchi","year":"1998","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2009.01.141_bib8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V86.2.726.bloodjournal862726","article-title":"Phosphatidylinositol-3 kinase activity is regulated by BCR\/ABL and is required for the growth of Philadelphia chromosome-positive cells","volume":"86","author":"Skorski","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2009.01.141_bib9","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.4049\/jimmunol.159.10.4720","article-title":"Constitutive activation of JAKs and STATs in BCR\u2013Abl-expressing cell lines and peripheral blood cells derived from leukemic patients","volume":"159","author":"Chai","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2009.01.141_bib10","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","article-title":"P210 and P190(BCR\/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members","volume":"271","author":"Ilaria","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2009.01.141_bib11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr\u2013Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2009.01.141_bib12","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"IRIS Investigators, five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2009.01.141_bib13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-145-12-200612190-00008","article-title":"New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance","volume":"145","author":"Kantarjian","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbrc.2009.01.141_bib14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrd2324","article-title":"Flying under the radar: the new wave of BCR\u2013ABL inhibitors","volume":"6","author":"Quint\u00e1s-Cardama","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2009.01.141_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(07)61165-9","article-title":"European LeukemiaNet, Chronic myeloid leukaemia","volume":"370","author":"Hehlmann","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2009.01.141_bib16","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","article-title":"Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy","volume":"16","author":"Hochhaus","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2009.01.141_bib17","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/cncr.20922","article-title":"Response and resistance in 300 patients with BCR\u2013ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up","volume":"103","author":"Lahaye","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2009.01.141_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1099480","article-title":"Overriding imatinib resistance with a novel ABL kinase inhibitor","volume":"305","author":"Shah","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2009.01.141_bib19","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1182\/blood-2005-11-4707","article-title":"Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825","volume":"107","author":"Abruzzese","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2009.01.141_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","article-title":"Characterization of AMN107, a selective inhibitor of native and mutant Bcr\u2013Abl","volume":"7","author":"Weisberg","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2009.01.141_bib21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/theoncologist.2007-0170","article-title":"Therapy options in imatinib failures","volume":"13","author":"Ramirez","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.bbrc.2009.01.141_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1541-7786.MCR-06-0208","article-title":"Roles of Aurora kinases in mitosis and tumorigenesis","volume":"5","author":"Fu","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbrc.2009.01.141_bib23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrm1245","article-title":"The cellular geography of aurora kinases","volume":"4","author":"Carmena","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2009.01.141_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nm1003","article-title":"VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo","volume":"10","author":"Harrington","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2009.01.141_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood-2006-05-025049","article-title":"MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR\u2013ABL mutation","volume":"109","author":"Giles","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2009.01.141_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/scd.2007.9994","article-title":"Depsipeptide (FK228) preferentially induces apoptosis in BCR\/ABL-expressing cell lines and cells from patients with chronic myelogenous leukemia in blast crisis","volume":"16","author":"Okabe","year":"2007","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.bbrc.2009.01.141_bib27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bcmd.2005.12.035","article-title":"Stromal-cell-derived factor-1\/CXCL12-induced chemotaxis of a T cell line involves intracellular signaling through Cbl and Cbl-b and their regulation by Src kinases and CD45","volume":"36","author":"Okabe","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbrc.2009.01.141_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1182\/blood-2004-03-0843","article-title":"Stromal cell-derived factor-1alpha\/CXCL12-induced chemotaxis of T cells involves activation of the RasGAP-associated docking protein p62Dok-1","volume":"105","author":"Okabe","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2009.01.141_bib29","doi-asserted-by":"crossref","first-page":"22925","DOI":"10.1016\/S0021-9258(17)31596-X","article-title":"Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia","volume":"269","author":"Oda","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2009.01.141_bib30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2009.01.141_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.canlet.2006.12.004","article-title":"Structural basis for potent inhibition of the Aurora kinases and a T315I multi-drug resistant mutant form of Abl kinase by VX-680","volume":"251","author":"Cheetham","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2009.01.141_bib32","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.289.5486.1938","article-title":"Structural mechanism for STI-571 inhibition of abelson tyrosine kinase","volume":"289","author":"Schindler","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2009.01.141_bib33","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/j.1349-7006.2007.00561.x","article-title":"Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis","volume":"98","author":"Tsutsumi","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2009.01.141_bib34","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.4161\/cc.5.22.3448","article-title":"Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties","volume":"22","author":"Garrido","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2009.01.141_bib35","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood-2004-05-2041","article-title":"Mechanistic role of heat shock protein 70 in Bcr\u2013Abl-mediated resistance to apoptosis in human acute leukemia cells","volume":"105","author":"Guo","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2009.01.141_bib36","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/pmic.200701035","article-title":"Proteomic analysis of an imatinib-resistant K562 cell line highlights opposing roles of heat shock cognate 70 and heat shock 70 proteins in resistance","volume":"12","author":"Pocaly","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.bbrc.2009.01.141_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.leu.2404463","article-title":"Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia","volume":"21","author":"Pocaly","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2009.01.141_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbrc.2007.08.054","article-title":"Hsp90 \u2014 from signal transduction to cell transformation","volume":"363","author":"Brown","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X09001971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X09001971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T20:06:11Z","timestamp":1710014771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X09001971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0006291X09001971"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2009.01.141","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}